PharmEasy (API Holdings Ltd) Unlisted Shares – Latest Price, Financials, Shareholding, Analysis & Investment Outlook
If you’re exploring opportunities in the unlisted and pre-IPO share market, PharmEasy unlisted shares have become a key attraction for long-term investors. Owned by API Holdings Ltd, PharmEasy is India’s leading digital healthcare platform offering online medicine delivery, diagnostics, teleconsultation, medical equipment, and pharma distribution. This article provides a complete breakdown of the latest PharmEasy unlisted share price, valuation, financial performance, business overview, shareholding pattern, risks, contact details and future IPO outlook.
Sell Price: ₹5.90 per share
52-Week Range: ₹5.10 – ₹665.00
Prices vary across dealers, demand, platform, and lot size.
About PharmEasy (API Holdings Ltd)
Founded in 2019, PharmEasy has revolutionized India’s healthcare accessibility. The company connects customers, pharmacies, doctors, diagnostic centers, and distributors into one integrated digital ecosystem. With strong brand recognition, scalable technology, and nationwide logistics, PharmEasy operates in India’s fast-growing digital health and e-pharmacy market. The company also owns Thyrocare Diagnostics, further strengthening its diagnostics footprint.
| Parameter | Details |
|---|---|
| Company Name | API Holdings Ltd (PharmEasy) |
| Industry | Digital Healthcare / e-Pharmacy |
| ISIN | INE0DJ201029 |
| Face Value | ₹1 |
| CIN | U60100MH2019PLC323444 |
| Headquarters | Mumbai, Maharashtra |
PharmEasy Unlisted Share Price — Platform Comparison
| Platform | Buy Price | Sell Price | Lot Size |
|---|---|---|---|
| DelistedStocks | ₹5.50 | ₹5.90 | 3,000 shares |
| UnlistedZone | — | ₹6.95 | 5,000 shares |
| Sharescart | — | ₹7.00 | Not disclosed |
| Altius Investech | ₹5.00 | ₹5.90 | Flexible |
PharmEasy Price Comparison Chart
PharmEasy Financial Performance (Consolidated Results)
| Financial Year | Total Income (₹ Cr) | Net Profit/Loss (₹ Cr) |
|---|---|---|
| FY 2025 | 5,872 | -1,572 |
| FY 2024 | 5,664 | -2,533 |
| FY 2023 | 6,644 | -5,211 |
Key Financial Ratios
| Metric | Value |
|---|---|
| Debt-Equity Ratio | 0.62 |
| P/B Ratio | 1.18 |
| Book Value per Share | ₹5.02 |
| Return on Equity | -48% |
PharmEasy Shareholding Pattern
| Shareholder Category | % Holding |
|---|---|
| Promoters | 65.40% |
| VC & Institutional Investors | 18.20% |
| Public & Others | 16.40% |
Corporate Contact Details — API Holdings Ltd
| Information | Details |
|---|---|
| Registered Office | 902, Raheja Plaza 1, B-Wing, Opp. R-City Mall, LBS Marg, Ghatkopar (W), Mumbai-400086 |
| Phone | +91-22-6255-6255 |
| corporatesecretarial@apiholdings.in | |
| Website | www.apiholdings.in |
Should You Invest in PharmEasy Unlisted Shares?
PharmEasy operates in a rapidly expanding digital healthcare sector and continues to build strong brand loyalty. However, the company remains loss-making with debt-related challenges and uncertain IPO timelines. Therefore, PharmEasy unlisted shares may be more suitable for high-risk, long-term investors who believe in the company’s future profitability and market leadership.
Final Investment Outlook
The long-term potential remains strong—especially if PharmEasy improves margins, reduces debt, and revives IPO plans. Investors should monitor valuations, financial stability, competition, and regulatory updates before entering the unlisted market.
Disclaimer
This article is informational and should not be considered investment advice. Unlisted shares involve pricing volatility, liquidity risk, and valuation uncertainty. Always consult a SEBI-registered financial advisor before investing.
